Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Acute Leukemias

Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution

Abstract

Acute erythroleukemia (AML-M6) is an uncommon subtype of acute myeloid leukemia (AML); it is considered to have a poor prognosis. From 1 January 1980 to 21 May 2008, 91 patients with newly diagnosed AML-M6 were seen at the University of Texas–M.D. Anderson Cancer Center (UT–MDACC). Forty-five patients (50%) had a history of myelodysplatic syndrome (MDS), compared with 41% in our control group (patients with other AML subtypes) (P=0.08). Poor-risk cytogenetics were more common in patients with AML-M6 (61% versus 38%, P=0.001). Complete remission rates were 62% for patients with AML-M6, comparing with 58% for the control group (P=0.35). Median disease free survival (DFS) for patients with AML-M6 was 32 weeks, versus 49 weeks for the control group (P=0.05). Median overall survival (OS) of patients with AML-M6 was 36 weeks, compared with 43 weeks for the control group (P=0.60). On multivariate analysis for DFS and OS, AML-M6 was not an independent risk factor. AML-M6 is commonly associated with a previous diagnosis of MDS and poor-risk karyotype. The diagnosis of AML-M6 does not impart by itself a worse prognosis, and treatment decisions on this disease should be guided by well known AML prognostic factors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Copelli M . Di una emopatia sistemizzata rapresentata da una imperplasia eritroblastica (eritronatosis). Pathologica 1912; 4: 460.

    Google Scholar 

  2. Di Guglielmo G . Richerche di ematologia. I. Un caso di eritroleucemia. Megacariociti in circolo e loro funzione piastrinopoietico. Folia Medica (Pavia) 1917; 13: 386.

    Google Scholar 

  3. Bain BJ . Di Guglielmo and his syndromes. Br J Haematol 2003; 120: 939–943.

    Article  Google Scholar 

  4. Di Guglielmo G . Eritremie acute. XXIX Congr Italiano Medical International; Roma, 1923.

    Google Scholar 

  5. Dameshek W, Baldini M . The Di Guglielmo syndrome. Blood 1958; 13: 192–194.

    CAS  PubMed  Google Scholar 

  6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458.

    Article  CAS  Google Scholar 

  7. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group. Ann Intern Med 1985; 103: 620–625.

    Article  CAS  Google Scholar 

  8. Brunning RD, Matutes E, Flandrin G, Vardiman JW, Bennett JM, Head DR et al. Acute myeloid leukemia not otherwise categorized. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001, pp 91–105.

    Google Scholar 

  9. Davey FR, Abraham Jr N, Brunetto VL, MacCallum JM, Nelson DA, Ball ED et al. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study. Am J Hematol 1995; 49: 29–38.

    Article  CAS  Google Scholar 

  10. Peterson BA, Levine EG . Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7. Semin Oncol 1987; 14: 425–434.

    CAS  PubMed  Google Scholar 

  11. Olopade OI, Thangavelu M, Larson RA, Mick R, Kowal-Vern A, Schumacher HR et al. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia. Blood 1992; 80: 2873–2882.

    CAS  PubMed  Google Scholar 

  12. Bennett JM, Begg CB . Eastern Cooperative Oncology Group study of the cytochemistry of adult acute myeloid leukemia by correlation of subtypes with response and survival. Cancer Res 1981; 41: 4833–4837.

    CAS  PubMed  Google Scholar 

  13. Lowenberg B . Prognostic factors in acute myeloid leukaemia. Best Pract Res 2001; 14: 65–75.

    Article  CAS  Google Scholar 

  14. Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG . Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group. Pediatr Blood Cancer 2007; 49: 17–22.

    Article  Google Scholar 

  15. Malkin D, Freedman MH . Childhood erythroleukemia: review of clinical and biological features. Am J Pediatr Hematol Oncol 1989, Fall 11: 348–359.

    CAS  PubMed  Google Scholar 

  16. Lazure T, Beauchamp A, Croisille L, Ferlicot S, Feneux D, Fabre M . Congenital anerythremic erythroleukemia presenting as hepatic failure. Arch Pathol Lab Med 2003; 127: 1362–1365.

    PubMed  Google Scholar 

  17. Novik Y, Marino P, Makower DF, Wiernik PH . Familial erythroleukemia: a distinct clinical and genetic type of familial leukemias. Leuk Lymphoma 1998; 30: 395–401.

    Article  CAS  Google Scholar 

  18. Nakamura H . Cytogenetic heterogeneity in erythroleukemia defined as M6 by the French–American–British (FAB) Cooperative Group criteria. Leukemia 1989; 3: 305–309.

    CAS  PubMed  Google Scholar 

  19. Atkinson J, Hrisinko MA, Weil SC . Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature. Blood Rev 1992; 6: 204–214.

    Article  CAS  Google Scholar 

  20. Lessard M, Struski S, Leymarie V, Flandrin G, Lafage-Pochitaloff M, Mozziconacci MJ et al. Cytogenetic study of 75 erythroleukemias. Cancer Genet Cytogenet 2005; 163: 113–122.

    Article  CAS  Google Scholar 

  21. Garand R, Duchayne E, Blanchard D, Robillard N, Kuhlein E, Fenneteau O et al. Minimally differentiated erythroleukaemia (AML M6 ‘variant’): a rare subset of AML distinct from AML M6. Groupe Francais d'Hematologie Cellulaire. Br J Haematol 1995; 90: 868–875.

    Article  CAS  Google Scholar 

  22. Greaves MF, Sieff C, Edwards PA . Monoclonal antiglycophorin as a probe for erythroleukemias. Blood 1983; 61: 645–651.

    CAS  PubMed  Google Scholar 

  23. Shichishima T . Minimally differentiated erythroleukemia: recognition of erythroid precursors and progenitors. Intern Med (Tokyo, Japan) 2000; 39: 761–762.

    Article  CAS  Google Scholar 

  24. Villeval JL, Cramer P, Lemoine F, Henri A, Bettaieb A, Bernaudin F et al. Phenotype of early erythroblastic leukemias. Blood 1986; 68: 1167–1174.

    CAS  PubMed  Google Scholar 

  25. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333.

    CAS  Google Scholar 

  26. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075–4083.

    CAS  PubMed  Google Scholar 

  27. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.

    Article  CAS  Google Scholar 

  28. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990; 8: 813–819.

    Article  CAS  Google Scholar 

  29. Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003; 21: 4642–4649.

    Article  Google Scholar 

  30. Snedecor G, Cochran W . Statistical Methods, 7th edn, Iowa State University Press: Armes, IA, 1980.

    Google Scholar 

  31. Kaplan EL, Meire P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

    Article  Google Scholar 

  32. Cox D . Regression models and life tables. J R Stat Soc 1972; 34: 187–202.

    Google Scholar 

  33. Colita A, Belhabri A, Chelghoum Y, Charrin C, Fiere D, Thomas X . Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases. Ann Oncol 2001; 12: 451–455.

    Article  CAS  Google Scholar 

  34. Cuneo A, Van Orshoven A, Michaux JL, Boogaerts M, Louwagie A, Doyen C et al. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Br J Haematol 1990; 75: 346–354.

    Article  CAS  Google Scholar 

  35. Cigudosa JC, Odero MD, Calasanz MJ, Sole F, Salido M, Arranz E et al. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes Cancer 2003; 36: 406–412.

    Article  CAS  Google Scholar 

  36. Park S, Picard F, Dreyfus F . Erythroleukemia: a need for a new definition. Leukemia 2002; 16: 1399–1401.

    Article  CAS  Google Scholar 

  37. Domingo-Claros A, Larriba I, Rozman M, Irriguible D, Vallespi T, Aventin A et al. Acute erythroid neoplastic proliferations. A biological study based on 62 patients. Haematologica 2002; 87: 148–153.

    PubMed  Google Scholar 

  38. Hayhoe FGJ, Quaglino D . Haematological Cytochemistry, 2nd edn, Churchill Livingstone: Edinburgh, 1988.

    Google Scholar 

  39. Frydecka I, Brodzka W, Lawinska B, Sciborski R . Clinical course and results of treatment of erythroleukaemia. Folia Haematol Int Mag Klin Morphol Blutforsch 1984; 111: 283–289.

    CAS  PubMed  Google Scholar 

  40. Fouillard L, Labopin M, Gorin NC, Polge E, Prentice HG, Meloni G et al. Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT). Blood 2002; 100: 3135–3140.

    Article  CAS  Google Scholar 

  41. Killick S, Matutes E, Powles RL, Min T, Treleaven JG, Rege KP et al. Acute erythroid leukemia (M6): outcome of bone marrow transplantation. Leuk Lymphoma 1999; 35: 99–107.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F Ravandi.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santos, F., Faderl, S., Garcia-Manero, G. et al. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia 23, 2275–2280 (2009). https://doi.org/10.1038/leu.2009.181

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2009.181

Keywords

This article is cited by

Search

Quick links